Evidence for involvement of ventral tegmental area cyclic amp systems in behavioral sensitization to psychostimulants

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 411-420

  Tolliver, Bryan K ^a   Ho, Lauren B ^a   Reid, Malcolm S ^a   Berger, S Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CHOLERA TOXIN; COCAINE; CYCLIC AMP; DEXAMPHETAMINE; DOPAMINE; MORPHINE SULFATE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CHOLERA TOXIN; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; TEGMENTUM MESENCEPHALI;

EID: 0030425586     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. AKIMOTO, K., HAMAMURA, T. AND OTSUKI, S.: Subchronic cocaine treatment enhances cocaine-induced dopamine efflux, studied by in vivo intracerebral dialysis. Brain Res. 490: 339-344, 1989.
2. BEITNEK-JOHNSON, D., GUITART, X. AND NESTLER, E. J.: Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins. Brain Res. 561: 146-149, 1991.
3. BEITNER-JOHNSON, D., GUITART, X. AND NESTUER, E. J.: Neurofilament proteins and the mesolimbic dopamine system: Common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12: 2165-2176, 1992.
4. BEITNER-JOHNSON, D. AND NESTLER, E. J.: Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57: 344-347, 1991.
5. BENINGER, R. J.: The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:173-196, 1983.
6. BYRNES, J. J., WEINSTEIN, D. M., URETSKY, N. J. AND WALLACE, L. J.: Microinjection of cholera toxin into the ventral tegmental area produces enhanced locomotor responses to subsequent amphetamine administration. Soc. Neurosci. Abs. 21: 971, 1995.
7. CAMERON, D. L. AND WILLIAMS, J. T.: Dopamine D1 receptors facilitate transmitter release. Nature (Lond.) 366: 344-347, 1993.
8. CARLSSON, M. AND CARLSSON, A.: Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13: 272-277, 1990.
9. COSTALL, B. AND NAYLOR, R. J.: Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat. In Cocaine and Other Stimulants, ed. by E. H. Ellinwood and M. M. Kilbey, pp. 47-76, Plenum Press, New York, 1977.
10. CUNNINGHAM, S. T. AND KELLEY, A. E.: Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J. Neurosci. 13: 2342-2350, 1993.
11. DOUGHEETY, G. G. AND ELLINWOOD, E. H.: Chronic d-amphetamine in nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity. Life Sci. 28: 2295-2298, 1981.
12. ELAZAR, Z. AND FUCHS, S.: Phosphorylation by cyclic AMP-dependent protein kinase modulates agonist binding to the D2 dopamine receptor. J. Neurochem. 56: 75-80, 1991.
13. ELLINWOOD, E. H., SUDILOVSKY, A. AND NELSON, L. M.: Evolving behavior in the clinical and experimental (model) amphetamine psychosis. Am. J. Psychiatry 130: 1088-1093, 1973.
14. GOODALE, D. B., RUSTERHOLZ, D. B., LONG, J. P., FLYNN, J. R., WALSH, B., CANNON, J. G. AND LEE, T.: Neurochemical and behavioral evidence of a selective presynaptic dopamine receptor agonist. Science (Wash. DC) 210:1141-1143, 1980.
15. GRAYBIEL, A. M.: Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13: 244-254, 1990.
16. HAGIWARA, M., INAGAKI, M. AND HIDAKA, H.: Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H8) to the active site of cAMP-dependent protein kinase. Mol. Pharmacol. 31: 523-527, 1987.
17. HENRY, D. J., GREENE, M. A. AND WHITE, F. J.: Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. J. Pharmacol. Exp. Ther. 251: 833-839, 1989.
18. HENRY, D. J. AND WHITE, F. J.: Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258: 882-890, 1991.
19. HENRY, D. J. AND WHITE, F. J.: The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neurosci. 15: 6287-6299, 1995.
20. HIDAKA, H., INAYAKI, M., KAWAMOTO, S. AND SASAKI, Y.: Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036-5041, 1984.
21. HITZMANN, R., WU, J., HOM, D. AND LOH, H.: Brain locations controlling the behavioral effects of chronic amphetamine intoxication. Psychopharmacology 72: 93-101, 1980.
22. HUANG, Y. Y., Li, X. C. AND KANDEL, E. R.: cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell 79: 69-79, 1994.
23. HUNTER, T. AND KARIN, M.: The regulation of transcription by phosphorylation. Cell 70: 375-387, 1992.
24. INNIS, R. B. AND AGHAJANIAN, G. K.: Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra. Brain Res. 411: 139-143, 1987.
25. JOH, T. H., PARK, D. H. AND REIS, D. J.: Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP-dependent protein kinase: Mechanism of enzyme activation. Proc. Natl. Acad. Sci. U.S.A 75: 4744-4748, 1978.
26. KALIVAS, P. W.: Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18: 75-113, 1993.
27. KALIVAS, P. W.: Blockade of neurotensin-induced motor activity by inhibition of protein kinase. Psychopharmacology 114: 175-180, 1994.
28. KALIVAS, P. W. AND ALESDATTER, J. E.: Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267: 486-495, 1993.
29. KALIVAS, P. W. AND DUFKY, P.: Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5: 48-58, 1990.
30. KALIVAS, P. W. AND DUFFY, P.: Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13: 266-275, 1993.
31. KALIVAS, P. W. AND DUFFY, P.: D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15: 5379-5388, 1995.
32. KALIVAS, P. W. AND STEWART, J.: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244, 1991.
33. KALIVAS, P. W. AND WEBER, B.: Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1988.
34. KAMATA, K. AND REBEC, G. V.: Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sci. 34: 2419-2427, 1984.
35. KEBABIAN, J. W. AND CALNE, D. B.: Multiple receptors for dopamine. Nature (Lond.) 277: 93-96, 1979.
36. KELLY, P. H. AND IVERSEN, S. D.: Selective 6-OHDA-induced destruction on mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40: 45-56, 1976.
37. KELLY, P. H., SEVIOR, P. W. AND IVERSEN, S. D.: Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
38. KIM, K. S., PARK, D. H., WESSEL, T. C., SONG, B., WAGNER, J. AND JOH, T. H.: A dual role for the cAMP-dependent protein kinase on tyrosine hydroxylase gene expression. Proc. Natl. Acad. Sci. U.S.A. 90: 3471-3475, 1993.
39. LE MOAL, M. AND SIMON, H.: Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiol. Rev. 71: 155-234, 1991.
40. MANJI, H. K.: G-proteins: Implications for psychiatry. Am. J. Psychiatry 149: 746-760, 1992.
41. MANSOUR, A., MEADOR-WOODRUFF, J. H., ZHOU, Q., CIVELLI, O., AKIL, H. AND WATSON, S. J.: A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46: 959-971, 1992.
42. MISERENDINO, M. J. D., GUITART, X., TERWILLIGER, R. Z., CHI, S. AND NESTLER, E. J.: Individual differences in locomotor activity are associated with levels of tyrosine hydroxylase and neurofilament proteins in the ventral tegmental area of Sprague-Dawley rats. Mol. Cell. Neurosci. 4: 440-448, 1993.
43. NESTLER, E. J. AND GREENGARD, P.: PROTEIN PHOSPHORYLATION AND THE REGULATION NEURONAL FUNCTION. IN BASIC NEUROCHEMISTRY: MOLECULAR, CELLULAR, AND MEDICAL ASPECTS, 5TH ED., ED. BY G. J. SIEGEL, B, W. AGRANOFF, R. W. ALBERS AND P. B. MOLINOFF, PP, 449-474, RAVEN PRESS, NEW YORK, 1994.
44. oα in discrete regions of rat brain. J. Neurochem. 55: 1079-1082, 1990.
45. OADES, R. D. AND HALLIDAY, G. M.: Ventral tegmental (A10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. 434: 117-165, 1987.
46. PARSONS, L. H. AND JUSTICE, J. B.: Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61: 1611-1619, 1993.
47. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
48. PERUGINI, M. AND VEZINA, P.: Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270: 690-696, 1994.
49. PIAZZA, P. V., DEMINIERE, J.-M., LE MOAL, M. AND SIMON, H.: Factors that predict individual vulnerability to amphetamine self-administration. Science (Wash. DC) 245: 1511-1513, 1989.
50. PIAZZA, P. V., DEMINIERE, J.-M., LE MOAL, M. AND SIMON, H.: Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514: 22-26, 1990.
51. POST, R. M.: Cocaine psychoses: A continuum model. Am. J. Psychiatry 132: 225-231, 1975.
52. POST, R. M., LOCKFELD, A., SQUILLACE, K. M. AND CONTEL, N. R.: Drug-environment interaction: Context-dependency of cocaine-induced behavioral sensitization. Life Sci. 28: 755-760, 1981.
53. RAYMOND, L. A., BLACKSTONE, C. D. AND HUGANIR, R. L.: Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase. Nature (Lond.) 361: 637-641, 1993.
54. 2 mechanisms in the development of stimulant sensitization. J. Pharmacol. Exp. Ther. 276:1244-1256, 1996.
55. ROBINSON, T. AND BECKER, J.: Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
56. SAITOH, M., ISHIKAWA, T., MATSUSHIMA, S., NAKA, M. AND HIDAKA, H.: Selective inhibition of catalytic activity of smooth muscle light chain kinase. J. Biol. Chem. 262: 7796-7801, 1987.
57. SCHREIBER, G., AVISSAR, S., DANON, A. AND BELMAKER, R. H.: Hyperfunctional G-proteins in mononuclear leukocytes of patients with mania. Biol. Psychiatry 29: 273-280, 1991.
58. SEGAL, D. S. AND KUCZENSKI, R.: In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 521: 330-332, 1992a.
59. SEGAL, D. S. AND KUCZENSKI, R.: Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577: 351-355, 1992b.
60. SHI, W.-X. AND BUNNEY, B. S.: Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons. J. Neurosci. 12: 2433-2438, 1992.
61. SNYDER, S. H.: Amphetamine psychosis: A "model" schizophrenia mediated by catecholamines. Am. J. Psychiatry 130: 61-67, 1973.
62. STEKETEE, J. D.: Intra-A10 injection of H7 blocks the development of sensitization to cocaine. NeuroReport 6: 69-72, 1994.
63. STEKETEE, J. D. AND KALIVAS, P. W.: Sensitization to psychostimulants and stress after injection of pertussis toxin into the AlO dopamine region. J. Pharmacol. Exp. Ther. 259: 916-924, 1991.
64. STEWART, J. AND VEZINA, P.: Conditioning and behavioral sensitization. In Sensitization in the Nervous System, ed. by P. W. Kalivas and C. D. Barnes, pp. 207-224, Telford Press, Caldwell, 1988.
65. STEWART, J. AND VEZINA, P.: Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495: 401-406, 1989.
66. STRIPLIN, C. D. AND KALIVAS, P. W.: Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 579: 181-186, 1992.
67. TERWILLIGER, R., BEITNER-JOHNSON, D., SVARINO, K. A., GRAIN, S. M. AND NESTLER, E. J.: A general role for adaptations in G-proteins and cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548: 100-110, 1991.
68. VACCARINO, F. J., AMALRIC, M., SWERDLOW, N. R. AND KOOB, G. F.: Blockade of amphetamine- but not opiate-induced locomotion following antagonism of dopamine function in the rat. Pharmacol. Biochem. Behav. 24: 61-65, 1986.
69. VEZINA, P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: An in viva microdialysis study in the rat. Brain Res. 605: 332-337, 1993.
70. VEZINA, P. AND STEWART, J.: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499: 108-120, 1989.
71. VEZINA, P. AND STEWART, J.: Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516: 99-106, 1990.
72. WALAAS, S. I. AND GREENGARD, P.: Protein phosphorylation and neuronal function. Pharmacol. Rev. 43: 299-349,1991.
73. WANG, L.-Y., SALTER, M. W. AND MACDONALD, J. F.: Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science (Wash. DC) 253: 1132-1135, 1991.
74. WEISSKOPF, M. G., CASTILLO, P. E., ZALUTSKY, R. A. AND NICOLL, R. A.: Mediation of hippocampal mossy fiber long-term potentiation by cyclic AMP. Science (Wash. DC) 265: 1878-1882, 1994.
75. WHITE, F. J., Hu, X.-T., ZHANG, X.-F. AND WOLF, M. E.: Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 273: 445-454, 1995.
76. WHITE, F. J. AND WANG, R. Y.: Electrophysiological evidence for AlO dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment. Brain Res. 309: 283-292, 1984a.
77. WHITE, F. J. AND WANG, R. Y.: A10 dopamine neurons: Role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci. 34: 1161-1170, 1984b.
78. WOLF, M. E., DAHLIN, S. L., HU, X.-T. AND XUE, C.-J.: Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: Comparison with N-methyl-D-aspartate antagonists. Neuroscience 69: 417-439, 1995.
79. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.